-
81
-
82
Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials
Published 2018-01-01Get full text
Article -
83
Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment
Published 2025-01-01Get full text
Article -
84
Transplant Tolerance: New Insights and Strategies for Long-Term Allograft Acceptance
Published 2013-01-01“…One of the greatest advances in medicine during the past century is the introduction of organ transplantation. This therapeutic strategy designed to treat organ failure and organ dysfunction allows to prolong the survival of many patients that are faced with no other treatment option. …”
Get full text
Article -
85
-
86
Immune Tolerance Regulation Is Critical to Immune Homeostasis
Published 2025-01-01“…Its induction or elimination plays a significant role in autoimmune diseases, organ transplantation, and cancer therapy, markedly impacting various major diseases in modern clinical practice. …”
Get full text
Article -
87
The Utilization of Imaging Features in the Management of Intraductal Papillary Mucinous Neoplasms
Published 2014-01-01Get full text
Article -
88
-
89
-
90
-
91
-
92
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
Published 2018-01-01Get full text
Article -
93
Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection
Published 2017-01-01“…Testing for preexisting and de novo immune responses to tissue-restricted SAgs and treatment based on immune responses after organ transplantation may improve short- and long-term outcomes after transplantation.…”
Get full text
Article -
94
Comment on: Age Matters. What Affects the Cumulative Lifespan of a Transplanted Liver?
Published 2024-06-01Get full text
Article -
95
-
96
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation
Published 2012-01-01“…In solid organ transplantation, ischemia/reperfusion (IR) injury during organ procurement, storage and reperfusion is an unavoidable detrimental event for the graft, as it amplifies graft inflammation and rejection. …”
Get full text
Article -
97
-
98
-
99
-
100
Mechanisms and Mediators of Inflammation: Potential Models for Skin Rejection and Targeted Therapy in Vascularized Composite Allotransplantation
Published 2012-01-01“…Blocking these molecules has not only shown success in the treatment of inflammatory dermatoses, but also prolonged graft survival in various models of solid organ transplantation. In addition to T cell recruitment, ectopic lymphoid structures within the allograft associated with chronic rejection in solid organ transplantation might contribute to the strong alloimmune response towards the skin. …”
Get full text
Article